Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

relacorilant MeSH Supplementary Concept Data 2025


MeSH Supplementary
relacorilant
Unique ID
C000633444
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000633444
Entry Term(s)
((4aR)-1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone
CORT125134
methanone, ((4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-
Registry Numbers
2158753C7E
Heading Mapped to
*Isoquinolines
*Pyrazoles
*Pyridines
Frequency
7
Note
an orally active, high-affinity, selective antagonist of the glucocorticoid receptor
Source
Clin Pharmacol Drug Dev. 2018 May;7(4):408-421.
Date of Entry
2019/08/12
Revision Date
2019/08/12
relacorilant Preferred
CORT125134 Narrower
((4aR)-1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone Broader
page delivered in 0.005s